New Report Explores Hottest Trends in Human Rotavirus Vaccine Market 2021-2025: International Key Vendors – GSK, Bharat Biotech, Merck

Global Human Rotavirus Vaccine Market Synopsis:

The report covers a forecast and an analysis of the Human Rotavirus Vaccine Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Human Rotavirus Vaccine Market along with the impact they have on the demand over the forecast period.

According to the market research study, Rotavirus Vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Rotavirus is a double-stranded RNA virus of the family Reoviridae and is transmitted through the faecal-oral route. Rotavirus infects the cell lining of the small intestine and causes gastroenteritis. As per the National Center for Biotechnology Information, rotavirus related diarrhoea was responsible for killing about 600,000 children in 2015, with more than 80% of all rotavirus-related deaths occurring in in South Asia and sub-Saharan Africa. Rotavirus-related deaths represent approximately 5% of all deaths in children younger than 5 years of age worldwide.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/288726 .

Some of the most significant key factors driving the growth of the Global Human Rotavirus Vaccine Market are rapid growth in the development and manufacturing of vaccine, increasing number of immunity-compromised individuals, growing geriatric population, increasing population and live births.

On the basis of Regional analysis, North America and Europe holds major share in global Human Rotavirus Vaccine market. Moreover, Asia-Pacific is expected to record higher growth rate in Human Rotavirus Vaccine Market during the forecast year.

This report contains a complete product overview and its scope in the market to define the key terms and provide the clients a holistic idea of the market and its tendency. It comprehensively evaluates the Global Human Rotavirus Vaccine Market with different perspectives for the purpose of providing a detailed, informative, and accurate analysis of regional growth, competition, market segmentation, and other important aspects.

Global Key Players:

1 Bharat Biotech

2 Merck

3 GlaxoSmithKline

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Human Rotavirus Vaccine Market Report 2021” @ https://www.businessindustryreports.com/buy-now/288726/single .

Product Type Segmentation

1 Rotarix

2 RotaTeq

3 Rotavac

4 Rotavin-M1

5 Lanzhou lamb

Industry Segmentation

1 Hospitals & Clinics

2 Academic And Research

Global Medical Industry News:

GlaxoSmithKline (GSK) (March 16, 2021) - Medicago and GSK start Phase 3 trial of adjuvanted COVID-19 vaccine candidate - Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) are pleased to announce the start of Phase 3 clinical testing of Medicago’s plant-derived COVID-19 vaccine candidate in combination with GSK’s pandemic adjuvant, as part of the ongoing Phase 2/3 study. Medicago received approval from Canadian and US regulatory authorities to proceed with enrolment of healthy adults in the Phase 3 portion of the trial based on positive interim Phase 2 results.

“We are pleased to take the significant step of initiating the Phase 3 clinical trial at sites around the world,” said Takashi Nagao, CEO and President of Medicago. “This brings us one step closer to delivering an important new COVID-19 vaccine and contributing to the global fight against the pandemic along with our partner GSK.”

Thomas Breuer, Chief Medical Officer, GSK Vaccines said, “This advance to late stage clinical testing further reinforces our confidence in the adjuvanted vaccine candidate’s potential to make a difference in the continued fight against COVID-19. We look forward to sharing results later this year.”

Medicago’s plant-derived vaccine candidate against COVID-19 uses Coronavirus-Like-Particle (CoVLP) technology with the vaccine composed of recombinant spike (S) glycoprotein expressed as virus-like-particles (VLPs) co-administered with GSK’s pandemic adjuvant. Two doses of 3.75μg of CoVLP are administered 21 days apart.

The vaccine candidate, in combination with the pandemic adjuvant, was granted Fast Track designation by the U.S. Food and Drug Administration (FDA) on 17 February 2021. Fast Track designation allows the FDA to expedite the development and review of new medicines and vaccines intended to treat or prevent serious conditions and address an unmet medical need.

“The FDA’s decision to grant Fast Track designation for Medicago’s vaccine candidate will help us expedite our efforts to bring the first plant-derived COVID-19 vaccine to market, subject to regulatory approval,” said Carolyn Finkle, Chief Operating Officer of Medicago. “We are grateful to the FDA and look forward to continuing to work with them as we move forward in our clinical trials, planned application for Emergency Use Authorisation and eventual vaccine licensure application process.”

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/288726 .

Major Points in Table of Contents:

Global Human Rotavirus Vaccine Market Report 2021

1 Human Rotavirus Vaccine Product Definition

2 Global Human Rotavirus Vaccine Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Human Rotavirus Vaccine Shipments

2.2 Global Manufacturer Human Rotavirus Vaccine Business Revenue

2.3 Global Human Rotavirus Vaccine Market Overview

2.4 COVID-19 Impact on Human Rotavirus Vaccine Industry

3 Manufacturer Human Rotavirus Vaccine Business Introduction

3.1 Bharat Biotech Human Rotavirus Vaccine Business Introduction

3.2 Merck Human Rotavirus Vaccine Business Introduction

3.3 GlaxoSmithKline Human Rotavirus Vaccine Business Introduction

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that hold the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.